샘플 요청 목록

 카트 문의
시장보고서
상품코드
1842257

세계의 생명과학용 차세대 고객 참여 플랫폼 시장 규모, 점유율, 동향 분석 : 구성요소별, 전개 방식별, 기능별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Life Sciences Next-generation Customer Engagement Platforms Market Size, Share & Trends Analysis Report By Component (Software, Services), By Deployment Mode, By Functionality, By End Use, By Region, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 190 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생명과학용 차세대 고객 참여 플랫폼 : 시장 개요

세계의 생명과학용 차세대 고객 참여 플랫폼 시장 규모는 2024년에 23억 7,000만 달러로 추정되며, 2033년에는 55억 6,000만 달러에 달할 것으로 예측되며, 2025년부터 2033년까지 CAGR은 10.13%로 성장할 전망입니다.

의료 서비스 제공자들은 점점 더 개인화된 진료에 중점을 두고 있으며, 상호 작용을 조정하고 환자 결과를 개선하기 위해 고도의 참여 플랫폼을 필요로 하고 있습니다.

의료 전문가 및 환자와의 맞춤형 대화에 대한 요구가 증가함에 따라 첨단 CEP 솔루션의 개발 및 구현이 촉진되고 있습니다. 환자 중심 치료로의 전환은 생명과학을 위한 차세대 고객 참여 플랫폼에 대한 수요를 가속화하고 있습니다. 기업들은 제품 판매 촉진뿐만 아니라 지속적인 지원과 교육, 결과에 초점을 맞춘 참여를 제공하는 디지털 도구가 필요하기 때문입니다. 예를 들어

2024년 10월, 테메디카와 로슈는 망막 질환을 위한 Retinora와 다발성 경화증에 대한 Brisa와 같은 디지털 컴패니언 앱을 통해 수만 명의 환자들에게 혜택을 주는 좋은 파트너십을 확대할 예정입니다. 테메디카 플랫폼에 구축되고 실제 증거와 통합된 이 앱들은 환자 치료를 개선하기 위한 개인화된 지원을 제공하며, 향후 확장될 예정입니다.

2022년 3월, 다리오헬스(DarioHealth)는 사노피(Sanofi U.S.)와 다년간 3,000만 달러 규모의 전략적 계약을 체결하여 다리오의 디지털 치료 플랫폼의 상업적 채택을 가속화하고 디지털 헬스 솔루션을 확장할 예정입니다. 이번 제휴는 다리오의 다중 질환 디지털 치료제의 판매 촉진, 의료 보험 제도 및 고용주 시장에서의 판매망 확대, 만성질환 관리를 개선하기 위한 새로운 솔루션 공동 개발 등을 목적으로 합니다.

2021년 9월, 젠젠텍(로슈)은 라이프링크시스템즈의 AI 기반 챗봇을 도입하여 임상시험에서 환자와의 커뮤니케이션을 개선했습니다. 이를 통해 24시간 365일 확장 가능하고 컴플라이언스를 준수하는 환자 접점을 관리할 수 있는 플랫폼의 필요성이 입증되었고, CEP의 도입을 직접적으로 촉진했습니다.

이러한 사례는 업계가 환자 중심 접근 방식을 참여 전략에 어떻게 도입하고 있는지를 보여줍니다. 디지털 컴패니언, AI 챗봇, 디지털 치료제 협업이 확대됨에 따라 생명과학 기업들은 이러한 툴을 통합하고, 컴플라이언스를 준수하는 상호 작용을 지원하며, 케어 생태계 전반에 걸쳐 측정 가능한 가치를 제공하는 고급 고객 고객 참여 플랫폼을 채택할 수밖에 없으며, 이는 궁극적으로 시장 성장을 촉진하고 있습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

  • 시장 연관 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 업계 기회 분석
    • 업계 과제 분석
    • 사례 연구
  • 비즈니스 환경 분석
    • Porter's Five Forces 분석
    • PESTLE 분석

제4장 생명과학용 차세대 고객 참여 플랫폼(CEP) 시장 : 구성요소별 추정·동향 분석

  • 구성요소별 대시보드
  • 시장 점유율과 변동 분석 : 구성요소별(2024년·2033년)
  • 시장 규모 예측과 동향 분석 : 구성요소별(2021-2033년)
  • 소프트웨어
  • 서비스(구현, 통합, 서포트)

제5장 생명과학용 차세대 고객 참여 플랫폼(CEP) 시장 : 전개 방식별 추정·동향 분석

  • 전개 방식별 대시보드
  • 시장 점유율과 변동 분석 : 전개 방식별(2024년·2033년)
  • 시장 규모 예측과 동향 분석 : 전개 방식별(2021-2033년)
  • 클라우드/SaaS(멀티테넌트, 구독)
  • 온프레미스

제6장 생명과학용 차세대 고객 참여 플랫폼(CEP) 시장 : 기능별 추정·동향 분석

  • 기능별 대시보드
  • 시장 점유율과 변동 분석 : 기능별(2024년·2033년)
  • 시장 규모 예측과 동향 분석 : 기능별(2021-2033년)
  • 코어·참여·층
    • 엔드 투 엔드 컨텐츠 관리
    • 참여 채널 최적화
    • 상업적 학습과 트레이닝
  • 고도 소프트웨어 기능
    • 인지 능력
    • 기능적 역할 범위

제7장 생명과학용 차세대 고객 참여 플랫폼(CEP) 시장 : 최종 용도별 추정·동향 분석

  • 최종 용도별 대시보드
  • 시장 점유율과 변동 분석 : 최종 용도별(2024년·2033년)
  • 시장 규모 예측과 동향 분석 : 최종 용도별(2021-2033년)
  • 제약 기업
  • 바이오테크놀러지 기업
  • 의료기기 기업
  • CRO(의약품 임상시험수탁기관)
  • 기타(연구기관 등을 포함)

제8장 생명과학용 차세대 고객 참여 플랫폼(CEP) 시장 : 지역별 추정·동향 분석

  • 시장 대시보드 : 지역별
  • 시장의 주요 포인트 : 지역별
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제9장 경쟁 구도

  • 진출 기업 개요
  • 기업의 시장 포지션 분석
  • 기업 분류
  • 전략 매핑
  • 기업 개요/상장 기업
    • Aktana, Inc
    • IQVIA(OCE)
    • Veeva Systems
    • Exeevo
    • Pitcher
    • Salesforce
    • ACTO Technologies Inc.
    • Allego
    • Bigtincan
    • ODAIA Intelligence Inc.
    • Qstream, Inc.
    • Seismic
    • Tellius
    • Viseven
    • Vodori
    • WhizAI
    • ZS Associates
    • Okra
    • P360
    • Quantified.ai
    • verbTEAMS
KSM 25.11.13

Life Sciences Next-generation Customer Engagement Platforms Market Summary

The global life sciences next-generation customer engagement platformsmarket size was estimated at USD 2.37 billion in 2024 and is projected to reach USD 5.56 billion by 2033, growing at a CAGR of 10.13% from 2025 to 2033. Healthcare providers increasingly focus on personalized care, necessitating advanced engagement platforms to tailor interactions and enhance patient outcomes.

Growing need for customized interactions with healthcare professionals and patients, driving the development and implementation of advanced CEP solutions. The shift toward patient-centric care is accelerating demand for life sciences next-generation customer engagement platforms, as companies need digital tools that go beyond product promotion to deliver continuous support, education, and outcomes-focused engagement. For instance:

In October 2024, Temedica and Roche extended their successful partnership, benefiting tens of thousands of patients with digital companion apps like Retinora for retinal diseases and Brisa for multiple sclerosis. These apps, built on Temedica's platform and integrated with real-world evidence, provide personalized support that improves patient care, with ongoing expansions planned.

In March 2022, DarioHealth entered into a multi-year, USD 30 million strategic agreement with Sanofi U.S. to accelerate the commercial adoption of Dario's digital therapeutics platform and expand digital health solutions. The collaboration aims to promote Dario's multi-condition digital therapeutics, increase sales reach in health plan and employer markets, and jointly develop new solutions to improve chronic disease management.

In September 2021, Genentech (Roche) deployed Lifelink Systems' AI-powered chatbot to improve patient communication in clinical trials. This demonstrated the need for platforms that can manage 24/7, scalable, and compliant patient touchpoints, which directly fuels CEP adoption.

These instances demonstrate how the industry is incorporating patient-centered approaches into engagement strategies. As digital companions, AI chatbots, and digital therapeutics collaborations grow, life sciences companies are compelled to adopt advanced customer engagement platforms that integrate these tools, support compliant interactions, and deliver measurable value across the care ecosystem, ultimately fueling market growth.

Global Life Sciences Next-generation Customer Engagement Platforms Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global life sciences next-generation customer engagement platforms market report based on component, deployment mode, functionality, end use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services (implementation, integration, support)
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud / SaaS (multi-tenant, subscription)
  • On-premise
  • Functionality Outlook (Revenue, USD Million, 2021 - 2033)
  • Core Engagement Layers
    • End to end content management
    • Engagement channel optimization
    • Commercial learning and training
  • Advanced Software Capabilities
    • Cognitive Capabilities
    • Functional Role Coverage
    • Sales
    • Marketing
    • Medical Affairs
    • Market Access
    • Patient Services
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Medical Device Firms
  • Others (Including Research Institutes, etc.)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Component
    • 1.2.2. Deployment Mode
    • 1.2.3. Functionality
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Shift toward patient-centered care
      • 3.2.1.2. Adoption of digital transformation in healthcare
      • 3.2.1.3. Demand for personalized customer engagement
      • 3.2.1.4. Integration of AI and machine learning
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Implementation Costs
      • 3.2.2.2. Data Privacy and Regulatory Compliance
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Component Estimates & Trend Analysis

  • 4.1. Component Segment Dashboard
  • 4.2. Component Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services (implementation, integration, support)
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Deployment Estimates & Trend Analysis

  • 5.1. Deployment Segment Dashboard
  • 5.2. Deployment Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Deployment, 2021 to 2033 (USD Million)
  • 5.4. Cloud / SaaS (multi-tenant, subscription)
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. On-premise
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Functionality Type Estimates & Trend Analysis

  • 6.1. Functionality Type Dashboard
  • 6.2. Functionality Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Functionality, 2021 to 2033 (USD Million)
  • 6.4. Core Engagement Layers
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. End to end content management
      • 6.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Engagement channel optimization
      • 6.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Commercial learning and training
      • 6.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Advanced Software Capabilities
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Cognitive Capabilities
      • 6.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Functional Role Coverage
      • 6.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.2. Sales
        • 6.5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.3. Marketing
        • 6.5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.4. Medical Affairs
        • 6.5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.5. Market Access
        • 6.5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.6. Patient Services
        • 6.5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2024 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical Companies
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Biotechnology Companies
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Medical Device Firms
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Contract Research Organizations (CROs)
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others (Including Research Institutes, etc.)
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market: Key Takeaways
  • 8.3. North America
    • 8.3.1. North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamic
      • 8.3.2.2. Regulatory framework
      • 8.3.2.3. Competitive insights
      • 8.3.2.4. U.S. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamic
      • 8.3.3.2. Regulatory framework
      • 8.3.3.3. Competitive insights
      • 8.3.3.4. Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamic
      • 8.3.4.2. Regulatory framework
      • 8.3.4.3. Competitive insights
      • 8.3.4.4. Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamic
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive insights
      • 8.4.2.4. Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key country dynamic
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive insights
      • 8.4.3.4. UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamic
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive insights
      • 8.4.4.4. France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamic
      • 8.4.5.2. Regulatory framework
      • 8.4.5.3. Competitive insights
      • 8.4.5.4. Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamic
      • 8.4.6.2. Regulatory framework
      • 8.4.6.3. Competitive insights
      • 8.4.6.4. Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key country dynamic
      • 8.4.7.2. Regulatory framework
      • 8.4.7.3. Competitive insights
      • 8.4.7.4. Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamic
      • 8.4.8.2. Regulatory framework
      • 8.4.8.3. Competitive insights
      • 8.4.8.4. Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamic
      • 8.4.9.2. Regulatory framework
      • 8.4.9.3. Competitive insights
      • 8.4.9.4. Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamic
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive insights
      • 8.5.2.4. Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamic
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive insights
      • 8.5.3.4. China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamic
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive insights
      • 8.5.4.4. India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamic
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive insights
      • 8.5.5.4. South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamic
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive insights
      • 8.5.6.4. Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamic
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive insights
      • 8.5.7.4. Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamic
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive insights
      • 8.6.2.4. Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamic
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive insights
      • 8.6.3.4. Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamic
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive insights
      • 8.7.2.4. South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamic
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive insights
      • 8.7.3.4. Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamic
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive insights
      • 8.7.4.4. UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamic
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive insights
      • 8.7.5.4. Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Aktana, Inc
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. IQVIA (OCE)
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Veeva Systems
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Exeevo
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Pitcher
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Salesforce
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. ACTO Technologies Inc.
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Allego
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Bigtincan
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. ODAIA Intelligence Inc.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Qstream, Inc.
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Seismic
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Tellius
      • 9.5.13.1. Overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Viseven
      • 9.5.14.1. Overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. Vodori
      • 9.5.15.1. Overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. WhizAI
      • 9.5.16.1. Overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. ZS Associates
      • 9.5.17.1. Overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. Okra
      • 9.5.18.1. Overview
      • 9.5.18.2. Financial performance
      • 9.5.18.3. Product benchmarking
      • 9.5.18.4. Strategic initiatives
    • 9.5.19. P360
      • 9.5.19.1. Overview
      • 9.5.19.2. Financial performance
      • 9.5.19.3. Product benchmarking
      • 9.5.19.4. Strategic initiatives
    • 9.5.20. Quantified.ai
      • 9.5.20.1. Overview
      • 9.5.20.2. Financial performance
      • 9.5.20.3. Product benchmarking
      • 9.5.20.4. Strategic initiatives
    • 9.5.21. verbTEAMS
      • 9.5.21.1. Overview
      • 9.5.21.2. Financial performance
      • 9.5.21.3. Product benchmarking
      • 9.5.21.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제